id	sid	tid	token	lemma	pos
ct-9332	1	1	introduction	introduction	NOUN
ct-9332	1	2	aglepristone	aglepristone	ADV
ct-9332	1	3	is	be	AUX
ct-9332	1	4	a	a	DET
ct-9332	1	5	competitive	competitive	ADJ
ct-9332	1	6	progesterone	progesterone	NOUN
ct-9332	1	7	antagonist	antagonist	NOUN
ct-9332	1	8	that	that	PRON
ct-9332	1	9	binds	bind	VERB
ct-9332	1	10	to	to	ADP
ct-9332	1	11	progesterone	progesterone	NOUN
ct-9332	1	12	receptors	receptor	NOUN
ct-9332	1	13	and	and	CCONJ
ct-9332	1	14	thereby	thereby	ADV
ct-9332	1	15	impairs	impair	VERB
ct-9332	1	16	the	the	DET
ct-9332	1	17	biological	biological	ADJ
ct-9332	1	18	effects	effect	NOUN
ct-9332	1	19	of	of	ADP
ct-9332	1	20	progesterone	progesterone	NOUN
ct-9332	1	21	.	.	PUNCT
ct-9332	2	1	it	it	PRON
ct-9332	2	2	is	be	AUX
ct-9332	2	3	an	an	DET
ct-9332	2	4	antiprogestin	antiprogestin	NOUN
ct-9332	2	5	,	,	PUNCT
ct-9332	2	6	with	with	ADP
ct-9332	2	7	similar	similar	ADJ
ct-9332	2	8	molecular	molecular	ADJ
ct-9332	2	9	structure	structure	NOUN
ct-9332	2	10	to	to	ADP
ct-9332	2	11	mifepristone	mifepristone	NOUN
ct-9332	2	12	used	use	VERB
ct-9332	2	13	in	in	ADP
ct-9332	2	14	human	human	ADJ
ct-9332	2	15	medicine	medicine	NOUN
ct-9332	2	16	.	.	PUNCT
ct-9332	3	1	its	its	PRON
ct-9332	3	2	affinity	affinity	NOUN
ct-9332	3	3	to	to	PART
ct-9332	3	4	progesterone	progesterone	NOUN
ct-9332	3	5	receptor	receptor	NOUN
ct-9332	3	6	is	be	AUX
ct-9332	3	7	3.12	3.12	NUM
ct-9332	3	8	and	and	CCONJ
ct-9332	3	9	9.26	9.26	NUM
ct-9332	3	10	times	time	NOUN
ct-9332	3	11	higher	high	ADJ
ct-9332	3	12	than	than	ADP
ct-9332	3	13	progesterone	progesterone	NOUN
ct-9332	3	14	for	for	ADP
ct-9332	3	15	the	the	DET
ct-9332	3	16	bitch	bitch	NOUN
ct-9332	3	17	and	and	CCONJ
ct-9332	3	18	queen	queen	NOUN
ct-9332	3	19	,	,	PUNCT
ct-9332	3	20	respectively.1	respectively.1	VERB
ct-9332	3	21	an	an	DET
ct-9332	3	22	aglepristone	aglepristone	ADJ
ct-9332	3	23	progesterone	progesterone	NOUN
ct-9332	3	24	compound	compound	NOUN
ct-9332	3	25	(	(	PUNCT
ct-9332	3	26	alizin	alizin	ADP
ct-9332	3	27	®	®	PROPN
ct-9332	3	28	[	[	X
ct-9332	3	29	virbac	virbac	ADJ
ct-9332	3	30	,	,	PUNCT
ct-9332	3	31	france	france	PROPN
ct-9332	3	32	]	]	PUNCT
ct-9332	3	33	)	)	PUNCT
ct-9332	3	34	is	be	AUX
ct-9332	3	35	approved	approve	VERB
ct-9332	3	36	in	in	ADP
ct-9332	3	37	europe	europe	PROPN
ct-9332	3	38	as	as	ADP
ct-9332	3	39	a	a	DET
ct-9332	3	40	subcutaneous	subcutaneous	ADJ
ct-9332	3	41	(	(	PUNCT
ct-9332	3	42	sc	sc	NOUN
ct-9332	3	43	)	)	PUNCT
ct-9332	3	44	injection	injection	NOUN
ct-9332	3	45	.	.	PUNCT
ct-9332	4	1	it	it	PRON
ct-9332	4	2	is	be	AUX
ct-9332	4	3	also	also	ADV
ct-9332	4	4	available	available	ADJ
ct-9332	4	5	in	in	ADP
ct-9332	4	6	australia	australia	PROPN
ct-9332	4	7	,	,	PUNCT
ct-9332	4	8	new	new	PROPN
ct-9332	4	9	zealand	zealand	PROPN
ct-9332	4	10	,	,	PUNCT
ct-9332	4	11	canada	canada	PROPN
ct-9332	4	12	and	and	CCONJ
ct-9332	4	13	in	in	ADP
ct-9332	4	14	the	the	DET
ct-9332	4	15	us	we	PRON
ct-9332	4	16	under	under	ADP
ct-9332	4	17	a	a	DET
ct-9332	4	18	controlled	control	VERB
ct-9332	4	19	use	use	NOUN
ct-9332	4	20	drug	drug	NOUN
ct-9332	4	21	prescription	prescription	NOUN
ct-9332	4	22	.	.	PUNCT
ct-9332	5	1	it	it	PRON
ct-9332	5	2	is	be	AUX
ct-9332	5	3	used	use	VERB
ct-9332	5	4	it	it	PRON
ct-9332	5	5	in	in	ADP
ct-9332	5	6	situations	situation	NOUN
ct-9332	5	7	wherein	wherein	SCONJ
ct-9332	5	8	the	the	DET
ct-9332	5	9	objective	objective	NOUN
ct-9332	5	10	is	be	AUX
ct-9332	5	11	to	to	PART
ct-9332	5	12	block	block	VERB
ct-9332	5	13	the	the	DET
ct-9332	5	14	progesterone	progesterone	NOUN
ct-9332	5	15	action	action	NOUN
ct-9332	5	16	(	(	PUNCT
ct-9332	5	17	reviewed1,2	reviewed1,2	PROPN
ct-9332	5	18	)	)	PUNCT
ct-9332	5	19	.	.	PUNCT
ct-9332	6	1	applications	application	NOUN
ct-9332	6	2	include	include	VERB
ct-9332	6	3	,	,	PUNCT
ct-9332	6	4	pregnancy	pregnancy	NOUN
ct-9332	6	5	termination	termination	NOUN
ct-9332	6	6	in	in	ADP
ct-9332	6	7	bitches	bitch	NOUN
ct-9332	6	8	(	(	PUNCT
ct-9332	6	9	only	only	ADV
ct-9332	6	10	approved	approve	VERB
ct-9332	6	11	indication	indication	NOUN
ct-9332	6	12	)	)	PUNCT
ct-9332	6	13	and	and	CCONJ
ct-9332	6	14	queen	queen	NOUN
ct-9332	6	15	,	,	PUNCT
ct-9332	6	16	medical	medical	ADJ
ct-9332	6	17	treatment	treatment	NOUN
ct-9332	6	18	of	of	ADP
ct-9332	6	19	pyometra	pyometra	NOUN
ct-9332	6	20	,	,	PUNCT
ct-9332	6	21	induction	induction	NOUN
ct-9332	6	22	of	of	ADP
ct-9332	6	23	parturition	parturition	NOUN
ct-9332	6	24	,	,	PUNCT
ct-9332	6	25	in	in	ADP
ct-9332	6	26	deciding	decide	VERB
ct-9332	6	27	elective	elective	ADJ
ct-9332	6	28	cesarean	cesarean	ADJ
ct-9332	6	29	section	section	NOUN
ct-9332	6	30	(	(	PUNCT
ct-9332	6	31	c	c	NOUN
ct-9332	6	32	-	-	PUNCT
ct-9332	6	33	section	section	NOUN
ct-9332	6	34	)	)	PUNCT
ct-9332	6	35	,	,	PUNCT
ct-9332	6	36	and	and	CCONJ
ct-9332	6	37	treatment	treatment	NOUN
ct-9332	6	38	of	of	ADP
ct-9332	6	39	feline	feline	ADJ
ct-9332	6	40	mammary	mammary	ADJ
ct-9332	6	41	fibroadenomatosis	fibroadenomatosis	NOUN
ct-9332	6	42	.	.	PUNCT
ct-9332	7	1	pregnancy	pregnancy	NOUN
ct-9332	7	2	termination	termination	NOUN
ct-9332	7	3	a	a	DET
ct-9332	7	4	case	case	NOUN
ct-9332	7	5	of	of	ADP
ct-9332	7	6	‘	'	PUNCT
ct-9332	7	7	misalliance	misalliance	NOUN
ct-9332	7	8	’	'	PUNCT
ct-9332	7	9	(	(	PUNCT
ct-9332	7	10	unwanted	unwanted	ADJ
ct-9332	7	11	mating	mating	NOUN
ct-9332	7	12	)	)	PUNCT
ct-9332	7	13	can	can	AUX
ct-9332	7	14	be	be	AUX
ct-9332	7	15	treated	treat	VERB
ct-9332	7	16	in	in	ADP
ct-9332	7	17	2	2	NUM
ct-9332	7	18	ways	way	NOUN
ct-9332	7	19	under	under	ADP
ct-9332	7	20	the	the	DET
ct-9332	7	21	supervision	supervision	NOUN
ct-9332	7	22	of	of	ADP
ct-9332	7	23	a	a	DET
ct-9332	7	24	licenced	licenced	ADJ
ct-9332	7	25	veterinarinan	veterinarinan	NOUN
ct-9332	7	26	.	.	PUNCT
ct-9332	8	1	either	either	CCONJ
ct-9332	8	2	a	a	DET
ct-9332	8	3	dose	dose	NOUN
ct-9332	8	4	of	of	ADP
ct-9332	8	5	alizin	alizin	PROPN
ct-9332	8	6	®	®	PROPN
ct-9332	8	7	(	(	PUNCT
ct-9332	8	8	10	10	NUM
ct-9332	8	9	mg	mg	NUM
ct-9332	8	10	/	/	SYM
ct-9332	8	11	kg	kg	PROPN
ct-9332	8	12	,	,	PUNCT
ct-9332	8	13	sc	sc	PROPN
ct-9332	8	14	)	)	PUNCT
ct-9332	8	15	is	be	AUX
ct-9332	8	16	given	give	VERB
ct-9332	8	17	after	after	ADP
ct-9332	8	18	end	end	NOUN
ct-9332	8	19	of	of	ADP
ct-9332	8	20	estrus	estrus	NOUN
ct-9332	8	21	(	(	PUNCT
ct-9332	8	22	confirmed	confirm	VERB
ct-9332	8	23	by	by	ADP
ct-9332	8	24	vaginal	vaginal	ADJ
ct-9332	8	25	cytology	cytology	NOUN
ct-9332	8	26	)	)	PUNCT
ct-9332	8	27	not	not	PART
ct-9332	8	28	knowing	know	VERB
ct-9332	8	29	if	if	SCONJ
ct-9332	8	30	the	the	DET
ct-9332	8	31	mating	mating	NOUN
ct-9332	8	32	resulted	result	VERB
ct-9332	8	33	in	in	ADP
ct-9332	8	34	a	a	DET
ct-9332	8	35	pregnancy	pregnancy	NOUN
ct-9332	8	36	,	,	PUNCT
ct-9332	8	37	or	or	CCONJ
ct-9332	8	38	terminating	terminate	VERB
ct-9332	8	39	pregnancy	pregnancy	NOUN
ct-9332	8	40	once	once	ADV
ct-9332	8	41	confirmed	confirm	VERB
ct-9332	8	42	by	by	ADP
ct-9332	8	43	ultrasonography	ultrasonography	NOUN
ct-9332	8	44	.	.	PUNCT
ct-9332	9	1	in	in	ADP
ct-9332	9	2	both	both	DET
ct-9332	9	3	cases	case	NOUN
ct-9332	9	4	,	,	PUNCT
ct-9332	9	5	a	a	DET
ct-9332	9	6	second	second	ADJ
ct-9332	9	7	dose	dose	NOUN
ct-9332	9	8	(	(	PUNCT
ct-9332	9	9	24	24	NUM
ct-9332	9	10	hours	hour	NOUN
ct-9332	9	11	later	later	ADV
ct-9332	9	12	)	)	PUNCT
ct-9332	9	13	is	be	AUX
ct-9332	9	14	necessary	necessary	ADJ
ct-9332	9	15	.	.	PUNCT
ct-9332	10	1	however	however	ADV
ct-9332	10	2	,	,	PUNCT
ct-9332	10	3	in	in	ADP
ct-9332	10	4	our	our	PRON
ct-9332	10	5	experience	experience	NOUN
ct-9332	10	6	,	,	PUNCT
ct-9332	10	7	a	a	DET
ct-9332	10	8	third	third	ADJ
ct-9332	10	9	dose	dose	NOUN
ct-9332	10	10	(	(	PUNCT
ct-9332	10	11	1	1	NUM
ct-9332	10	12	week	week	NOUN
ct-9332	10	13	after	after	ADP
ct-9332	10	14	the	the	DET
ct-9332	10	15	first	first	ADJ
ct-9332	10	16	injection	injection	NOUN
ct-9332	10	17	)	)	PUNCT
ct-9332	10	18	is	be	AUX
ct-9332	10	19	necessary	necessary	ADJ
ct-9332	10	20	for	for	ADP
ct-9332	10	21	most	most	ADV
ct-9332	10	22	pregnant	pregnant	ADJ
ct-9332	10	23	dogs	dog	NOUN
ct-9332	10	24	.	.	PUNCT
ct-9332	11	1	although	although	SCONJ
ct-9332	11	2	the	the	DET
ct-9332	11	3	efficacy	efficacy	NOUN
ct-9332	11	4	at	at	ADP
ct-9332	11	5	the	the	DET
ct-9332	11	6	end	end	NOUN
ct-9332	11	7	of	of	ADP
ct-9332	11	8	estrus	estrus	NOUN
ct-9332	11	9	is	be	AUX
ct-9332	11	10	higher	high	ADJ
ct-9332	11	11	than	than	ADP
ct-9332	11	12	95	95	NUM
ct-9332	11	13	%	%	NOUN
ct-9332	11	14	,	,	PUNCT
ct-9332	11	15	it	it	PRON
ct-9332	11	16	is	be	AUX
ct-9332	11	17	worthwhile	worthwhile	ADJ
ct-9332	11	18	to	to	PART
ct-9332	11	19	examine	examine	VERB
ct-9332	11	20	for	for	ADP
ct-9332	11	21	pregnancy	pregnancy	NOUN
ct-9332	11	22	.	.	PUNCT
ct-9332	12	1	additionally	additionally	ADV
ct-9332	12	2	,	,	PUNCT
ct-9332	12	3	cases	case	NOUN
ct-9332	12	4	of	of	ADP
ct-9332	12	5	pregnancy	pregnancy	NOUN
ct-9332	12	6	termination	termination	NOUN
ct-9332	12	7	should	should	AUX
ct-9332	12	8	be	be	AUX
ct-9332	12	9	followed	follow	VERB
ct-9332	12	10	antiprogestin	antiprogestin	NOUN
ct-9332	12	11	use	use	NOUN
ct-9332	12	12	in	in	ADP
ct-9332	12	13	europe	europe	PROPN
ct-9332	12	14	cindy	cindy	PROPN
ct-9332	12	15	maenhoudt	maenhoudt	PROPN
ct-9332	12	16	,	,	PUNCT
ct-9332	12	17	alain	alain	PROPN
ct-9332	12	18	fontbonne	fontbonne	PROPN
ct-9332	12	19	ecole	ecole	PROPN
ct-9332	12	20	nationale	nationale	PROPN
ct-9332	12	21	vétérinaire	vétérinaire	PROPN
ct-9332	12	22	d’alfort	d’alfort	PROPN
ct-9332	12	23	,	,	PUNCT
ct-9332	12	24	centre	centre	PROPN
ct-9332	12	25	d’etude	d’etude	NOUN
ct-9332	12	26	en	en	ADP
ct-9332	12	27	reproduction	reproduction	NOUN
ct-9332	12	28	des	des	X
ct-9332	12	29	carnivores	carnivore	VERB
ct-9332	12	30	maisons	maison	NOUN
ct-9332	12	31	-	-	PUNCT
ct-9332	12	32	alfort	alfort	NOUN
ct-9332	12	33	(	(	PUNCT
ct-9332	12	34	paris	paris	PROPN
ct-9332	12	35	)	)	PUNCT
ct-9332	12	36	,	,	PUNCT
ct-9332	12	37	france	france	PROPN
ct-9332	12	38	abstract	abstract	ADJ
ct-9332	12	39	aglepristone	aglepristone	PROPN
ct-9332	12	40	is	be	AUX
ct-9332	12	41	a	a	DET
ct-9332	12	42	competitive	competitive	ADJ
ct-9332	12	43	progesterone	progesterone	NOUN
ct-9332	12	44	antagonist	antagonist	NOUN
ct-9332	12	45	that	that	PRON
ct-9332	12	46	binds	bind	VERB
ct-9332	12	47	to	to	ADP
ct-9332	12	48	progesterone	progesterone	NOUN
ct-9332	12	49	receptors	receptor	NOUN
ct-9332	12	50	and	and	CCONJ
ct-9332	12	51	is	be	AUX
ct-9332	12	52	used	use	VERB
ct-9332	12	53	in	in	ADP
ct-9332	12	54	small	small	ADJ
ct-9332	12	55	animal	animal	NOUN
ct-9332	12	56	reproductive	reproductive	ADJ
ct-9332	12	57	management	management	NOUN
ct-9332	12	58	.	.	PUNCT
ct-9332	13	1	this	this	DET
ct-9332	13	2	article	article	NOUN
ct-9332	13	3	is	be	AUX
ct-9332	13	4	a	a	DET
ct-9332	13	5	brief	brief	ADJ
ct-9332	13	6	review	review	NOUN
ct-9332	13	7	of	of	ADP
ct-9332	13	8	the	the	DET
ct-9332	13	9	following	follow	VERB
ct-9332	13	10	aspects	aspect	NOUN
ct-9332	13	11	:	:	PUNCT
ct-9332	13	12	approved	approve	VERB
ct-9332	13	13	use	use	NOUN
ct-9332	13	14	in	in	ADP
ct-9332	13	15	pregnancy	pregnancy	NOUN
ct-9332	13	16	termination	termination	NOUN
ct-9332	13	17	in	in	ADP
ct-9332	13	18	bitches	bitch	NOUN
ct-9332	13	19	and	and	CCONJ
ct-9332	13	20	queens	queen	NOUN
ct-9332	13	21	;	;	PUNCT
ct-9332	13	22	medical	medical	ADJ
ct-9332	13	23	treatment	treatment	NOUN
ct-9332	13	24	of	of	ADP
ct-9332	13	25	pyometra	pyometra	NOUN
ct-9332	13	26	;	;	PUNCT
ct-9332	13	27	induction	induction	NOUN
ct-9332	13	28	of	of	ADP
ct-9332	13	29	parturition	parturition	NOUN
ct-9332	13	30	;	;	PUNCT
ct-9332	13	31	planning	plan	VERB
ct-9332	13	32	of	of	ADP
ct-9332	13	33	an	an	DET
ct-9332	13	34	elective	elective	ADJ
ct-9332	13	35	cesarean	cesarean	ADJ
ct-9332	13	36	section	section	NOUN
ct-9332	13	37	;	;	PUNCT
ct-9332	13	38	and	and	CCONJ
ct-9332	13	39	treatment	treatment	NOUN
ct-9332	13	40	of	of	ADP
ct-9332	13	41	feline	feline	ADJ
ct-9332	13	42	mammary	mammary	ADJ
ct-9332	13	43	fibroadenomatosis	fibroadenomatosis	NOUN
ct-9332	13	44	.	.	PUNCT
ct-9332	14	1	keywords	keyword	NOUN
ct-9332	14	2	:	:	PUNCT
ct-9332	14	3	aglepristone	aglepristone	ADJ
ct-9332	14	4	,	,	PUNCT
ct-9332	14	5	antiprogesterone	antiprogesterone	NOUN
ct-9332	14	6	,	,	PUNCT
ct-9332	14	7	small	small	ADJ
ct-9332	14	8	animals	animal	NOUN
ct-9332	14	9	,	,	PUNCT
ct-9332	14	10	reproductive	reproductive	ADJ
ct-9332	14	11	management	management	NOUN
ct-9332	14	12	(	(	PUNCT
ct-9332	14	13	1	1	NUM
ct-9332	14	14	week	week	NOUN
ct-9332	14	15	later	later	ADV
ct-9332	14	16	)	)	PUNCT
ct-9332	14	17	by	by	ADP
ct-9332	14	18	abdominal	abdominal	ADJ
ct-9332	14	19	ultrasonography	ultrasonography	NOUN
ct-9332	14	20	to	to	PART
ct-9332	14	21	ensure	ensure	VERB
ct-9332	14	22	that	that	SCONJ
ct-9332	14	23	pregnancy	pregnancy	NOUN
ct-9332	14	24	is	be	AUX
ct-9332	14	25	arrested	arrest	VERB
ct-9332	14	26	(	(	PUNCT
ct-9332	14	27	no	no	DET
ct-9332	14	28	viable	viable	ADJ
ct-9332	14	29	embryo	embryo	NOUN
ct-9332	14	30	/	/	SYM
ct-9332	14	31	fetuses	fetus	NOUN
ct-9332	14	32	remaining	remain	VERB
ct-9332	14	33	)	)	PUNCT
ct-9332	14	34	and	and	CCONJ
ct-9332	14	35	evaluate	evaluate	VERB
ct-9332	14	36	the	the	DET
ct-9332	14	37	amount	amount	NOUN
ct-9332	14	38	of	of	ADP
ct-9332	14	39	fluid	fluid	NOUN
ct-9332	14	40	in	in	ADP
ct-9332	14	41	the	the	DET
ct-9332	14	42	uterine	uterine	ADJ
ct-9332	14	43	lumen	luman	NOUN
ct-9332	14	44	.	.	PUNCT
ct-9332	15	1	although	although	SCONJ
ct-9332	15	2	the	the	DET
ct-9332	15	3	efficacy	efficacy	NOUN
ct-9332	15	4	of	of	ADP
ct-9332	15	5	the	the	DET
ct-9332	15	6	product	product	NOUN
ct-9332	15	7	is	be	AUX
ct-9332	15	8	closer	close	ADJ
ct-9332	15	9	to	to	PART
ct-9332	15	10	100	100	NUM
ct-9332	15	11	%	%	NOUN
ct-9332	15	12	,	,	PUNCT
ct-9332	15	13	in	in	ADP
ct-9332	15	14	late	late	ADJ
ct-9332	15	15	pregnancy	pregnancy	NOUN
ct-9332	15	16	(	(	PUNCT
ct-9332	15	17	>	>	X
ct-9332	15	18	38	38	NUM
ct-9332	15	19	days	day	NOUN
ct-9332	15	20	)	)	PUNCT
ct-9332	15	21	it	it	PRON
ct-9332	15	22	may	may	AUX
ct-9332	15	23	require	require	VERB
ct-9332	15	24	repeated	repeat	VERB
ct-9332	15	25	treatment	treatment	NOUN
ct-9332	15	26	for	for	ADP
ct-9332	15	27	total	total	ADJ
ct-9332	15	28	efficacy	efficacy	NOUN
ct-9332	15	29	.	.	PUNCT
ct-9332	16	1	treatment	treatment	NOUN
ct-9332	16	2	failure	failure	NOUN
ct-9332	16	3	is	be	AUX
ct-9332	16	4	rare	rare	ADJ
ct-9332	16	5	.	.	PUNCT
ct-9332	17	1	pregnancy	pregnancy	NOUN
ct-9332	17	2	termination	termination	NOUN
ct-9332	17	3	(	(	PUNCT
ct-9332	17	4	before	before	ADP
ct-9332	17	5	45	45	NUM
ct-9332	17	6	days	day	NOUN
ct-9332	17	7	)	)	PUNCT
ct-9332	17	8	is	be	AUX
ct-9332	17	9	the	the	DET
ct-9332	17	10	only	only	ADJ
ct-9332	17	11	indication	indication	NOUN
ct-9332	17	12	for	for	ADP
ct-9332	17	13	approved	approved	ADJ
ct-9332	17	14	use	use	NOUN
ct-9332	17	15	.	.	PUNCT
ct-9332	18	1	therefore	therefore	ADV
ct-9332	18	2	,	,	PUNCT
ct-9332	18	3	alizin	alizin	ADP
ct-9332	18	4	®	®	NOUN
ct-9332	18	5	use	use	NOUN
ct-9332	18	6	in	in	ADP
ct-9332	18	7	pregnancies	pregnancy	NOUN
ct-9332	18	8	over	over	ADP
ct-9332	18	9	45	45	NUM
ct-9332	18	10	days	day	NOUN
ct-9332	18	11	is	be	AUX
ct-9332	18	12	not	not	PART
ct-9332	18	13	recommended	recommend	VERB
ct-9332	18	14	and	and	CCONJ
ct-9332	18	15	is	be	AUX
ct-9332	18	16	also	also	ADV
ct-9332	18	17	‘	'	PUNCT
ct-9332	18	18	off	off	ADP
ct-9332	18	19	-	-	PUNCT
ct-9332	18	20	label	label	NOUN
ct-9332	18	21	.	.	PUNCT
ct-9332	18	22	’	'	PUNCT
ct-9332	19	1	side	side	NOUN
ct-9332	19	2	effects	effect	NOUN
ct-9332	19	3	vary	vary	VERB
ct-9332	19	4	and	and	CCONJ
ct-9332	19	5	seem	seem	VERB
ct-9332	19	6	to	to	PART
ct-9332	19	7	be	be	AUX
ct-9332	19	8	associated	associate	VERB
ct-9332	19	9	with	with	ADP
ct-9332	19	10	the	the	DET
ct-9332	19	11	onset	onset	NOUN
ct-9332	19	12	of	of	ADP
ct-9332	19	13	the	the	DET
ct-9332	19	14	treatment	treatment	NOUN
ct-9332	19	15	in	in	ADP
ct-9332	19	16	relation	relation	NOUN
ct-9332	19	17	to	to	ADP
ct-9332	19	18	the	the	DET
ct-9332	19	19	stage	stage	NOUN
ct-9332	19	20	of	of	ADP
ct-9332	19	21	pregnancy	pregnancy	NOUN
ct-9332	19	22	.	.	PUNCT
ct-9332	20	1	following	follow	VERB
ct-9332	20	2	signs	sign	NOUN
ct-9332	20	3	were	be	AUX
ct-9332	20	4	observed	observe	VERB
ct-9332	20	5	:	:	PUNCT
ct-9332	20	6	anorexia	anorexia	ADJ
ct-9332	20	7	and/or	and/or	CCONJ
ct-9332	20	8	depression	depression	NOUN
ct-9332	20	9	(	(	PUNCT
ct-9332	20	10	with	with	ADP
ct-9332	20	11	weight	weight	NOUN
ct-9332	20	12	loss	loss	NOUN
ct-9332	20	13	)	)	PUNCT
ct-9332	20	14	,	,	PUNCT
ct-9332	20	15	vomiting	vomiting	NOUN
ct-9332	20	16	,	,	PUNCT
ct-9332	20	17	diarrhea	diarrhea	PROPN
ct-9332	20	18	,	,	PUNCT
ct-9332	20	19	and	and	CCONJ
ct-9332	20	20	polydipsia	polydipsia	NOUN
ct-9332	20	21	.	.	PUNCT
ct-9332	21	1	vaginal	vaginal	ADJ
ct-9332	21	2	discharge	discharge	NOUN
ct-9332	21	3	,	,	PUNCT
ct-9332	21	4	if	if	SCONJ
ct-9332	21	5	observed	observe	VERB
ct-9332	21	6	,	,	PUNCT
ct-9332	21	7	started	start	VERB
ct-9332	21	8	within	within	ADP
ct-9332	21	9	2	2	NUM
ct-9332	21	10	days	day	NOUN
ct-9332	21	11	after	after	ADP
ct-9332	21	12	the	the	DET
ct-9332	21	13	onset	onset	NOUN
ct-9332	21	14	of	of	ADP
ct-9332	21	15	treatment	treatment	NOUN
ct-9332	21	16	and	and	CCONJ
ct-9332	21	17	lasted	last	VERB
ct-9332	21	18	1	1	NUM
ct-9332	21	19	2	2	NUM
ct-9332	21	20	weeks	week	NOUN
ct-9332	21	21	in	in	ADP
ct-9332	21	22	bitches	bitch	NOUN
ct-9332	21	23	that	that	PRON
ct-9332	21	24	were	be	AUX
ct-9332	21	25	at	at	ADV
ct-9332	21	26	least	least	ADV
ct-9332	21	27	30	30	NUM
ct-9332	21	28	days	day	NOUN
ct-9332	21	29	pregnant	pregnant	ADJ
ct-9332	21	30	.	.	PUNCT
ct-9332	22	1	its	its	PRON
ct-9332	22	2	use	use	NOUN
ct-9332	22	3	in	in	ADP
ct-9332	22	4	a	a	DET
ct-9332	22	5	late	late	ADJ
ct-9332	22	6	stage	stage	NOUN
ct-9332	22	7	of	of	ADP
ct-9332	22	8	pregnancy	pregnancy	NOUN
ct-9332	22	9	(	(	PUNCT
ct-9332	22	10	~	~	PUNCT
ct-9332	22	11	40	40	NUM
ct-9332	22	12	days	day	NOUN
ct-9332	22	13	)	)	PUNCT
ct-9332	22	14	can	can	AUX
ct-9332	22	15	lead	lead	VERB
ct-9332	22	16	to	to	ADP
ct-9332	22	17	fetal	fetal	ADJ
ct-9332	22	18	expulsion	expulsion	NOUN
ct-9332	22	19	.	.	PUNCT
ct-9332	23	1	it	it	PRON
ct-9332	23	2	must	must	AUX
ct-9332	23	3	be	be	AUX
ct-9332	23	4	noted	note	VERB
ct-9332	23	5	that	that	SCONJ
ct-9332	23	6	alizin	alizin	NOUN
ct-9332	23	7	®	®	NOUN
ct-9332	23	8	shortens	shorten	VERB
ct-9332	23	9	the	the	DET
ct-9332	23	10	interestrus	interestrus	NOUN
ct-9332	23	11	interval	interval	NOUN
ct-9332	23	12	.	.	PUNCT
ct-9332	24	1	terminating	terminate	VERB
ct-9332	24	2	unwanted	unwanted	ADJ
ct-9332	24	3	pregnancies	pregnancy	NOUN
ct-9332	24	4	in	in	ADP
ct-9332	24	5	the	the	DET
ct-9332	24	6	queen	queen	NOUN
ct-9332	24	7	with	with	ADP
ct-9332	24	8	alizin	alizin	NOUN
ct-9332	24	9	®	®	NOUN
ct-9332	24	10	is	be	AUX
ct-9332	24	11	‘	'	PUNCT
ct-9332	24	12	off	off	ADP
ct-9332	24	13	-	-	PUNCT
ct-9332	24	14	label	label	NOUN
ct-9332	24	15	.	.	PUNCT
ct-9332	24	16	’	'	PUNCT
ct-9332	25	1	when	when	SCONJ
ct-9332	25	2	used	use	VERB
ct-9332	25	3	as	as	ADV
ct-9332	25	4	early	early	ADV
ct-9332	25	5	as	as	ADP
ct-9332	25	6	days	day	NOUN
ct-9332	25	7	5	5	NUM
ct-9332	25	8	6	6	NUM
ct-9332	25	9	after	after	ADP
ct-9332	25	10	mating	mating	NOUN
ct-9332	25	11	,	,	PUNCT
ct-9332	25	12	the	the	DET
ct-9332	25	13	success	success	NOUN
ct-9332	25	14	was	be	AUX
ct-9332	25	15	closer	close	ADJ
ct-9332	25	16	to	to	ADP
ct-9332	25	17	100%,3	100%,3	NUM
ct-9332	25	18	termination	termination	NOUN
ct-9332	25	19	rates	rate	NOUN
ct-9332	25	20	decreased	decrease	VERB
ct-9332	25	21	to	to	ADP
ct-9332	25	22	~	~	PUNCT
ct-9332	25	23	88	88	NUM
ct-9332	25	24	%	%	NOUN
ct-9332	25	25	between	between	ADP
ct-9332	25	26	days	day	NOUN
ct-9332	25	27	25	25	NUM
ct-9332	25	28	35	35	NUM
ct-9332	25	29	.	.	PUNCT
ct-9332	26	1	the	the	DET
ct-9332	26	2	efficacy	efficacy	NOUN
ct-9332	26	3	is	be	AUX
ct-9332	26	4	as	as	ADV
ct-9332	26	5	low	low	ADJ
ct-9332	26	6	as	as	ADP
ct-9332	26	7	67	67	NUM
ct-9332	26	8	%	%	NOUN
ct-9332	26	9	in	in	ADP
ct-9332	26	10	queens	queen	NOUN
ct-9332	26	11	treated	treat	VERB
ct-9332	26	12	after	after	ADP
ct-9332	26	13	45	45	NUM
ct-9332	26	14	days	day	NOUN
ct-9332	26	15	of	of	ADP
ct-9332	26	16	pregnancy2	pregnancy2	NOUN
ct-9332	26	17	and	and	CCONJ
ct-9332	26	18	therefore	therefore	ADV
ct-9332	26	19	it	it	PRON
ct-9332	26	20	is	be	AUX
ct-9332	26	21	not	not	PART
ct-9332	26	22	advised	advise	VERB
ct-9332	26	23	for	for	ADP
ct-9332	26	24	a	a	DET
ct-9332	26	25	late	late	ADJ
ct-9332	26	26	stage	stage	NOUN
ct-9332	26	27	.	.	PUNCT
ct-9332	27	1	pyometra	pyometra	ADJ
ct-9332	27	2	management	management	NOUN
ct-9332	27	3	alizin	alizin	PROPN
ct-9332	27	4	®	®	NOUN
ct-9332	27	5	(	(	PUNCT
ct-9332	27	6	10	10	NUM
ct-9332	27	7	mg	mg	NUM
ct-9332	27	8	/	/	SYM
ct-9332	27	9	kg	kg	PROPN
ct-9332	27	10	,	,	PUNCT
ct-9332	27	11	sc	sc	PROPN
ct-9332	27	12	)	)	PUNCT
ct-9332	27	13	can	can	AUX
ct-9332	27	14	be	be	AUX
ct-9332	27	15	used	use	VERB
ct-9332	27	16	in	in	ADP
ct-9332	27	17	breeding	breed	VERB
ct-9332	27	18	animals	animal	NOUN
ct-9332	27	19	that	that	PRON
ct-9332	27	20	have	have	VERB
ct-9332	27	21	no	no	DET
ct-9332	27	22	systemic	systemic	ADJ
ct-9332	27	23	complications	complication	NOUN
ct-9332	27	24	.	.	PUNCT
ct-9332	28	1	absence	absence	NOUN
ct-9332	28	2	of	of	ADP
ct-9332	28	3	ovarian	ovarian	ADJ
ct-9332	28	4	pathologies	pathology	NOUN
ct-9332	28	5	(	(	PUNCT
ct-9332	28	6	e.g.	e.g.	ADV
ct-9332	28	7	ovarian	ovarian	ADJ
ct-9332	28	8	cysts	cyst	NOUN
ct-9332	28	9	)	)	PUNCT
ct-9332	28	10	is	be	AUX
ct-9332	28	11	important	important	ADJ
ct-9332	28	12	before	before	ADP
ct-9332	28	13	beginning	begin	VERB
ct-9332	28	14	of	of	ADP
ct-9332	28	15	treatment	treatment	NOUN
ct-9332	28	16	.	.	PUNCT
ct-9332	29	1	two	two	NUM
ct-9332	29	2	initial	initial	ADJ
ct-9332	29	3	injections	injection	NOUN
ct-9332	29	4	are	be	AUX
ct-9332	29	5	given	give	VERB
ct-9332	29	6	24	24	NUM
ct-9332	29	7	hours	hour	NOUN
ct-9332	29	8	apart	apart	ADV
ct-9332	29	9	,	,	PUNCT
ct-9332	29	10	followed	follow	VERB
ct-9332	29	11	by	by	ADP
ct-9332	29	12	clinical	clinical	ADJ
ct-9332	29	13	theriogenology	theriogenology	NOUN
ct-9332	29	14	2021	2021	NUM
ct-9332	29	15	;	;	PUNCT
ct-9332	29	16	13	13	NUM
ct-9332	29	17	:	:	SYM
ct-9332	29	18	159	159	NUM
ct-9332	29	19	weekly	weekly	ADJ
ct-9332	29	20	injections	injection	NOUN
ct-9332	29	21	until	until	ADP
ct-9332	29	22	complete	complete	ADJ
ct-9332	29	23	recovery	recovery	NOUN
ct-9332	29	24	.	.	PUNCT
ct-9332	30	1	a	a	DET
ct-9332	30	2	modified	modify	VERB
ct-9332	30	3	protocol	protocol	NOUN
ct-9332	30	4	(	(	PUNCT
ct-9332	30	5	injections	injection	NOUN
ct-9332	30	6	at	at	ADP
ct-9332	30	7	day	day	NOUN
ct-9332	30	8	0	0	NUM
ct-9332	30	9	,	,	PUNCT
ct-9332	30	10	2	2	NUM
ct-9332	30	11	,	,	PUNCT
ct-9332	30	12	5	5	NUM
ct-9332	30	13	,	,	PUNCT
ct-9332	30	14	and	and	CCONJ
ct-9332	30	15	8)	8)	NUM
ct-9332	30	16	had	have	VERB
ct-9332	30	17	high	high	ADJ
ct-9332	30	18	efficacy	efficacy	NOUN
ct-9332	30	19	and	and	CCONJ
ct-9332	30	20	there	there	PRON
ct-9332	30	21	was	be	VERB
ct-9332	30	22	no	no	DET
ct-9332	30	23	recurrence	recurrence	NOUN
ct-9332	30	24	within	within	ADP
ct-9332	30	25	24	24	NUM
ct-9332	30	26	months.4	months.4	PROPN
ct-9332	30	27	vaginal	vaginal	ADJ
ct-9332	30	28	discharge	discharge	NOUN
ct-9332	30	29	is	be	AUX
ct-9332	30	30	observed	observe	VERB
ct-9332	30	31	within	within	ADP
ct-9332	30	32	a	a	DET
ct-9332	30	33	few	few	ADJ
ct-9332	30	34	hours	hour	NOUN
ct-9332	30	35	after	after	ADP
ct-9332	30	36	the	the	DET
ct-9332	30	37	first	first	ADJ
ct-9332	30	38	injection	injection	NOUN
ct-9332	30	39	.	.	PUNCT
ct-9332	31	1	it	it	PRON
ct-9332	31	2	is	be	AUX
ct-9332	31	3	recommended	recommend	VERB
ct-9332	31	4	that	that	SCONJ
ct-9332	31	5	treated	treat	VERB
ct-9332	31	6	animals	animal	NOUN
ct-9332	31	7	do	do	AUX
ct-9332	31	8	not	not	PART
ct-9332	31	9	ingest	ingest	VERB
ct-9332	31	10	the	the	DET
ct-9332	31	11	vulvar	vulvar	ADJ
ct-9332	31	12	discharge	discharge	NOUN
ct-9332	31	13	and	and	CCONJ
ct-9332	31	14	an	an	DET
ct-9332	31	15	elizabethan	elizabethan	PROPN
ct-9332	31	16	collar	collar	NOUN
ct-9332	31	17	is	be	AUX
ct-9332	31	18	recommended	recommend	VERB
ct-9332	31	19	.	.	PUNCT
ct-9332	32	1	additionally	additionally	ADV
ct-9332	32	2	,	,	PUNCT
ct-9332	32	3	it	it	PRON
ct-9332	32	4	is	be	AUX
ct-9332	32	5	important	important	ADJ
ct-9332	32	6	to	to	PART
ct-9332	32	7	combine	combine	VERB
ct-9332	32	8	the	the	DET
ct-9332	32	9	treatment	treatment	NOUN
ct-9332	32	10	with	with	ADP
ct-9332	32	11	other	other	ADJ
ct-9332	32	12	therapies	therapy	NOUN
ct-9332	32	13	such	such	ADJ
ct-9332	32	14	as	as	ADP
ct-9332	32	15	antibiotics	antibiotic	NOUN
ct-9332	32	16	,	,	PUNCT
ct-9332	32	17	fluid	fluid	NOUN
ct-9332	32	18	therapy	therapy	NOUN
ct-9332	32	19	,	,	PUNCT
ct-9332	32	20	and	and	CCONJ
ct-9332	32	21	correction	correction	NOUN
ct-9332	32	22	of	of	ADP
ct-9332	32	23	gastrointestinal	gastrointestinal	ADJ
ct-9332	32	24	signs	sign	NOUN
ct-9332	32	25	.	.	PUNCT
ct-9332	33	1	the	the	DET
ct-9332	33	2	success	success	NOUN
ct-9332	33	3	rate	rate	NOUN
ct-9332	33	4	is	be	AUX
ct-9332	33	5	over	over	ADP
ct-9332	33	6	80	80	NUM
ct-9332	33	7	%	%	NOUN
ct-9332	33	8	.	.	PUNCT
ct-9332	34	1	although	although	SCONJ
ct-9332	34	2	,	,	PUNCT
ct-9332	34	3	the	the	DET
ct-9332	34	4	combination	combination	NOUN
ct-9332	34	5	of	of	ADP
ct-9332	34	6	aglepristone	aglepristone	NOUN
ct-9332	34	7	with	with	ADP
ct-9332	34	8	cloprostenol	cloprostenol	NOUN
ct-9332	34	9	is	be	AUX
ct-9332	34	10	described	describe	VERB
ct-9332	34	11	,	,	PUNCT
ct-9332	34	12	it	it	PRON
ct-9332	34	13	is	be	AUX
ct-9332	34	14	not	not	PART
ct-9332	34	15	used	use	VERB
ct-9332	34	16	frequently	frequently	ADV
ct-9332	34	17	in	in	ADP
ct-9332	34	18	our	our	PRON
ct-9332	34	19	clinic	clinic	NOUN
ct-9332	34	20	.	.	PUNCT
ct-9332	35	1	subsequent	subsequent	ADJ
ct-9332	35	2	fertility	fertility	NOUN
ct-9332	35	3	appears	appear	VERB
ct-9332	35	4	to	to	PART
ct-9332	35	5	be	be	AUX
ct-9332	35	6	not	not	PART
ct-9332	35	7	affected	affect	VERB
ct-9332	35	8	by	by	ADP
ct-9332	35	9	alizin	alizin	NOUN
ct-9332	35	10	®	®	NOUN
ct-9332	35	11	treatment	treatment	NOUN
ct-9332	35	12	.	.	PUNCT
ct-9332	36	1	parturition	parturition	NOUN
ct-9332	36	2	induction	induction	NOUN
ct-9332	36	3	inducing	induce	VERB
ct-9332	36	4	parturition	parturition	NOUN
ct-9332	36	5	and	and	CCONJ
ct-9332	36	6	more	more	ADV
ct-9332	36	7	frequently	frequently	ADV
ct-9332	36	8	,	,	PUNCT
ct-9332	36	9	scheduling	schedule	VERB
ct-9332	36	10	a	a	DET
ct-9332	36	11	c	c	NOUN
ct-9332	36	12	-	-	PUNCT
ct-9332	36	13	section	section	NOUN
ct-9332	36	14	,	,	PUNCT
ct-9332	36	15	are	be	AUX
ct-9332	36	16	indications	indication	NOUN
ct-9332	36	17	for	for	ADP
ct-9332	36	18	alizin	alizin	PROPN
ct-9332	36	19	®	®	PROPN
ct-9332	36	20	.	.	PUNCT
ct-9332	37	1	since	since	SCONJ
ct-9332	37	2	induction	induction	NOUN
ct-9332	37	3	of	of	ADP
ct-9332	37	4	parturition	parturition	NOUN
ct-9332	37	5	is	be	AUX
ct-9332	37	6	not	not	PART
ct-9332	37	7	a	a	DET
ct-9332	37	8	current	current	ADJ
ct-9332	37	9	request	request	NOUN
ct-9332	37	10	of	of	ADP
ct-9332	37	11	clientele	clientele	PROPN
ct-9332	37	12	,	,	PUNCT
ct-9332	37	13	limited	limited	ADJ
ct-9332	37	14	data	datum	NOUN
ct-9332	37	15	are	be	AUX
ct-9332	37	16	available	available	ADJ
ct-9332	37	17	in	in	ADP
ct-9332	37	18	clinical	clinical	ADJ
ct-9332	37	19	setting	setting	NOUN
ct-9332	37	20	.	.	PUNCT
ct-9332	38	1	in	in	ADP
ct-9332	38	2	the	the	DET
ct-9332	38	3	studies	study	NOUN
ct-9332	38	4	performed	perform	VERB
ct-9332	38	5	to	to	PART
ct-9332	38	6	evaluate	evaluate	VERB
ct-9332	38	7	the	the	DET
ct-9332	38	8	efficacy	efficacy	NOUN
ct-9332	38	9	of	of	ADP
ct-9332	38	10	aglepristone	aglepristone	NOUN
ct-9332	38	11	to	to	PART
ct-9332	38	12	induce	induce	VERB
ct-9332	38	13	parturition	parturition	NOUN
ct-9332	38	14	,	,	PUNCT
ct-9332	38	15	the	the	DET
ct-9332	38	16	results	result	NOUN
ct-9332	38	17	were	be	AUX
ct-9332	38	18	similar	similar	ADJ
ct-9332	38	19	to	to	ADP
ct-9332	38	20	normal	normal	ADJ
ct-9332	38	21	parturition	parturition	NOUN
ct-9332	38	22	.	.	PUNCT
ct-9332	39	1	timing	timing	NOUN
ct-9332	39	2	of	of	ADP
ct-9332	39	3	induction	induction	NOUN
ct-9332	39	4	used	use	VERB
ct-9332	39	5	for	for	ADP
ct-9332	39	6	beagle	beagle	NOUN
ct-9332	39	7	bitches	bitch	NOUN
ct-9332	39	8	was	be	AUX
ct-9332	39	9	60	60	NUM
ct-9332	39	10	days	day	NOUN
ct-9332	39	11	after	after	SCONJ
ct-9332	39	12	estimated	estimate	VERB
ct-9332	39	13	lh	lh	PROPN
ct-9332	39	14	surge5	surge5	PROPN
ct-9332	39	15	and	and	CCONJ
ct-9332	39	16	in	in	ADP
ct-9332	39	17	other	other	ADJ
ct-9332	39	18	breeds	breed	NOUN
ct-9332	39	19	it	it	PRON
ct-9332	39	20	was	be	AUX
ct-9332	39	21	59	59	NUM
ct-9332	39	22	61	61	NUM
ct-9332	39	23	days	day	NOUN
ct-9332	39	24	postovulation.6	postovulation.6	NOUN
ct-9332	39	25	oxytocin	oxytocin	NOUN
ct-9332	39	26	was	be	AUX
ct-9332	39	27	also	also	ADV
ct-9332	39	28	used	use	VERB
ct-9332	39	29	in	in	ADP
ct-9332	39	30	the	the	DET
ct-9332	39	31	above	above	ADJ
ct-9332	39	32	studies	study	NOUN
ct-9332	39	33	.	.	PUNCT
ct-9332	40	1	induction	induction	NOUN
ct-9332	40	2	in	in	ADP
ct-9332	40	3	bitches	bitch	NOUN
ct-9332	40	4	over	over	ADP
ct-9332	40	5	20	20	NUM
ct-9332	40	6	kg	kg	NOUN
ct-9332	40	7	was	be	AUX
ct-9332	40	8	less	less	ADV
ct-9332	40	9	effective	effective	ADJ
ct-9332	40	10	.	.	PUNCT
ct-9332	41	1	for	for	ADP
ct-9332	41	2	the	the	DET
ct-9332	41	3	elective	elective	ADJ
ct-9332	41	4	planned	plan	VERB
ct-9332	41	5	c	c	NOUN
ct-9332	41	6	-	-	PUNCT
ct-9332	41	7	section	section	NOUN
ct-9332	41	8	cases	case	NOUN
ct-9332	41	9	,	,	PUNCT
ct-9332	41	10	the	the	DET
ct-9332	41	11	protocol	protocol	NOUN
ct-9332	41	12	is	be	AUX
ct-9332	41	13	to	to	PART
ct-9332	41	14	follow	follow	VERB
ct-9332	41	15	the	the	DET
ct-9332	41	16	bitch	bitch	NOUN
ct-9332	41	17	after	after	ADP
ct-9332	41	18	60	60	NUM
ct-9332	41	19	days	day	NOUN
ct-9332	41	20	from	from	ADP
ct-9332	41	21	a	a	DET
ct-9332	41	22	well	well	ADV
ct-9332	41	23	-	-	PUNCT
ct-9332	41	24	estimated	estimate	VERB
ct-9332	41	25	ovulation	ovulation	NOUN
ct-9332	41	26	date	date	NOUN
ct-9332	41	27	to	to	PART
ct-9332	41	28	decide	decide	VERB
ct-9332	41	29	the	the	DET
ct-9332	41	30	time	time	NOUN
ct-9332	41	31	of	of	ADP
ct-9332	41	32	alizin	alizin	PROPN
ct-9332	41	33	®	®	NOUN
ct-9332	41	34	injection	injection	NOUN
ct-9332	41	35	(	(	PUNCT
ct-9332	41	36	15	15	NUM
ct-9332	41	37	mg	mg	PROPN
ct-9332	41	38	/	/	SYM
ct-9332	41	39	kg	kg	PROPN
ct-9332	41	40	sc	sc	PROPN
ct-9332	41	41	)	)	PUNCT
ct-9332	41	42	.	.	PUNCT
ct-9332	42	1	serum	serum	PROPN
ct-9332	42	2	progesterone	progesterone	NOUN
ct-9332	42	3	concentrations	concentration	NOUN
ct-9332	42	4	are	be	AUX
ct-9332	42	5	evaluated	evaluate	VERB
ct-9332	42	6	to	to	PART
ct-9332	42	7	ensure	ensure	VERB
ct-9332	42	8	that	that	SCONJ
ct-9332	42	9	the	the	DET
ct-9332	42	10	bitch	bitch	NOUN
ct-9332	42	11	has	have	AUX
ct-9332	42	12	not	not	PART
ct-9332	42	13	started	start	VERB
ct-9332	42	14	parturition	parturition	NOUN
ct-9332	42	15	(	(	PUNCT
ct-9332	42	16	i.e.	i.e.	X
ct-9332	42	17	it	it	PRON
ct-9332	42	18	is	be	AUX
ct-9332	42	19	not	not	PART
ct-9332	42	20	at	at	ADP
ct-9332	42	21	term	term	NOUN
ct-9332	42	22	)	)	PUNCT
ct-9332	42	23	and	and	CCONJ
ct-9332	42	24	the	the	DET
ct-9332	42	25	injection	injection	NOUN
ct-9332	42	26	is	be	AUX
ct-9332	42	27	given	give	VERB
ct-9332	42	28	no	no	DET
ct-9332	42	29	more	more	ADJ
ct-9332	42	30	than	than	ADP
ct-9332	42	31	18	18	NUM
ct-9332	42	32	hours	hour	NOUN
ct-9332	42	33	before	before	ADP
ct-9332	42	34	the	the	DET
ct-9332	42	35	surgery	surgery	NOUN
ct-9332	42	36	to	to	PART
ct-9332	42	37	avoid	avoid	VERB
ct-9332	42	38	onset	onset	NOUN
ct-9332	42	39	of	of	ADP
ct-9332	42	40	parturition	parturition	NOUN
ct-9332	42	41	.	.	PUNCT
ct-9332	43	1	ultrasonography	ultrasonography	NOUN
ct-9332	43	2	is	be	AUX
ct-9332	43	3	necessary	necessary	ADJ
ct-9332	43	4	to	to	PART
ct-9332	43	5	evaluate	evaluate	VERB
ct-9332	43	6	fetal	fetal	ADJ
ct-9332	43	7	viability	viability	NOUN
ct-9332	43	8	and	and	CCONJ
ct-9332	43	9	maturation.7	maturation.7	PROPN
ct-9332	43	10	in	in	ADP
ct-9332	43	11	our	our	PRON
ct-9332	43	12	experience	experience	NOUN
ct-9332	43	13	,	,	PUNCT
ct-9332	43	14	verifying	verify	VERB
ct-9332	43	15	milk	milk	NOUN
ct-9332	43	16	secretion	secretion	NOUN
ct-9332	43	17	before	before	SCONJ
ct-9332	43	18	the	the	DET
ct-9332	43	19	procedure	procedure	NOUN
ct-9332	43	20	was	be	AUX
ct-9332	43	21	necessary	necessary	ADJ
ct-9332	43	22	to	to	PART
ct-9332	43	23	decrease	decrease	VERB
ct-9332	43	24	the	the	DET
ct-9332	43	25	risk	risk	NOUN
ct-9332	43	26	of	of	ADP
ct-9332	43	27	agalactia	agalactia	PROPN
ct-9332	43	28	/	/	SYM
ct-9332	43	29	hypogalactia	hypogalactia	NOUN
ct-9332	43	30	in	in	ADP
ct-9332	43	31	the	the	DET
ct-9332	43	32	first	first	ADJ
ct-9332	43	33	24	24	NUM
ct-9332	43	34	hours	hour	NOUN
ct-9332	43	35	after	after	ADP
ct-9332	43	36	c	c	NOUN
ct-9332	43	37	-	-	PUNCT
ct-9332	43	38	section	section	NOUN
ct-9332	43	39	.	.	PUNCT
ct-9332	44	1	our	our	PRON
ct-9332	44	2	collective	collective	ADJ
ct-9332	44	3	data	datum	NOUN
ct-9332	44	4	from	from	ADP
ct-9332	44	5	the	the	DET
ct-9332	44	6	last	last	ADJ
ct-9332	44	7	10	10	NUM
ct-9332	44	8	years	year	NOUN
ct-9332	44	9	had	have	VERB
ct-9332	44	10	a	a	DET
ct-9332	44	11	neonatal	neonatal	ADJ
ct-9332	44	12	mortality	mortality	NOUN
ct-9332	44	13	(	(	PUNCT
ct-9332	44	14	in	in	ADP
ct-9332	44	15	the	the	DET
ct-9332	44	16	first	first	ADJ
ct-9332	44	17	2	2	NUM
ct-9332	44	18	weeks	week	NOUN
ct-9332	44	19	of	of	ADP
ct-9332	44	20	life	life	NOUN
ct-9332	44	21	)	)	PUNCT
ct-9332	44	22	after	after	SCONJ
ct-9332	44	23	planned	plan	VERB
ct-9332	44	24	c	c	NOUN
ct-9332	44	25	-	-	PUNCT
ct-9332	44	26	section	section	NOUN
ct-9332	44	27	was	be	AUX
ct-9332	44	28	9.89	9.89	NUM
ct-9332	44	29	%	%	NOUN
ct-9332	44	30	.	.	PUNCT
ct-9332	45	1	dead	dead	ADJ
ct-9332	45	2	puppies	puppy	NOUN
ct-9332	45	3	were	be	AUX
ct-9332	45	4	not	not	PART
ct-9332	45	5	further	far	ADV
ct-9332	45	6	examined	examine	VERB
ct-9332	45	7	,	,	PUNCT
ct-9332	45	8	but	but	CCONJ
ct-9332	45	9	no	no	DET
ct-9332	45	10	obvious	obvious	ADJ
ct-9332	45	11	signs	sign	NOUN
ct-9332	45	12	of	of	ADP
ct-9332	45	13	prematurity	prematurity	NOUN
ct-9332	45	14	were	be	AUX
ct-9332	45	15	observed	observe	VERB
ct-9332	45	16	at	at	ADP
ct-9332	45	17	the	the	DET
ct-9332	45	18	time	time	NOUN
ct-9332	45	19	of	of	ADP
ct-9332	45	20	c	c	NOUN
ct-9332	45	21	-	-	PUNCT
ct-9332	45	22	section.8	section.8	NOUN
ct-9332	45	23	this	this	PRON
ct-9332	45	24	is	be	AUX
ct-9332	45	25	a	a	DET
ct-9332	45	26	safe	safe	ADJ
ct-9332	45	27	procedure	procedure	NOUN
ct-9332	45	28	to	to	PART
ct-9332	45	29	avoid	avoid	VERB
ct-9332	45	30	dystocia	dystocia	NOUN
ct-9332	45	31	.	.	PUNCT
ct-9332	46	1	for	for	ADP
ct-9332	46	2	feline	feline	ADJ
ct-9332	46	3	mammary	mammary	ADJ
ct-9332	46	4	hyperplasia	hyperplasia	NOUN
ct-9332	46	5	although	although	SCONJ
ct-9332	46	6	this	this	DET
ct-9332	46	7	tumor	tumor	NOUN
ct-9332	46	8	can	can	AUX
ct-9332	46	9	regress	regress	NOUN
ct-9332	46	10	spontaneously	spontaneously	ADV
ct-9332	46	11	,	,	PUNCT
ct-9332	46	12	the	the	DET
ct-9332	46	13	hormonal	hormonal	ADJ
ct-9332	46	14	component	component	NOUN
ct-9332	46	15	of	of	ADP
ct-9332	46	16	the	the	DET
ct-9332	46	17	disease	disease	NOUN
ct-9332	46	18	(	(	PUNCT
ct-9332	46	19	exposure	exposure	NOUN
ct-9332	46	20	to	to	ADP
ct-9332	46	21	progesterone	progesterone	NOUN
ct-9332	46	22	)	)	PUNCT
ct-9332	46	23	supports	support	VERB
ct-9332	46	24	alizin	alizin	NOUN
ct-9332	46	25	®	®	NOUN
ct-9332	46	26	as	as	ADP
ct-9332	46	27	a	a	DET
ct-9332	46	28	treatment	treatment	NOUN
ct-9332	46	29	option	option	NOUN
ct-9332	46	30	.	.	PUNCT
ct-9332	47	1	the	the	DET
ct-9332	47	2	protocol	protocol	NOUN
ct-9332	47	3	is	be	AUX
ct-9332	47	4	injections	injection	NOUN
ct-9332	47	5	(	(	PUNCT
ct-9332	47	6	15	15	NUM
ct-9332	47	7	mg	mg	PROPN
ct-9332	47	8	/	/	SYM
ct-9332	47	9	kg	kg	PROPN
ct-9332	47	10	,	,	PUNCT
ct-9332	47	11	sc	sc	PROPN
ct-9332	47	12	)	)	PUNCT
ct-9332	47	13	on	on	ADP
ct-9332	47	14	days	day	NOUN
ct-9332	47	15	1	1	NUM
ct-9332	47	16	and	and	CCONJ
ct-9332	47	17	2	2	NUM
ct-9332	47	18	,	,	PUNCT
ct-9332	47	19	then	then	ADV
ct-9332	47	20	once	once	ADV
ct-9332	47	21	per	per	ADP
ct-9332	47	22	week	week	NOUN
ct-9332	47	23	until	until	ADP
ct-9332	47	24	complete	complete	ADJ
ct-9332	47	25	regression	regression	NOUN
ct-9332	47	26	of	of	ADP
ct-9332	47	27	mammary	mammary	ADJ
ct-9332	47	28	lesions	lesion	NOUN
ct-9332	47	29	.	.	PUNCT
ct-9332	48	1	the	the	DET
ct-9332	48	2	success	success	NOUN
ct-9332	48	3	rate	rate	NOUN
ct-9332	48	4	is	be	AUX
ct-9332	48	5	over	over	ADP
ct-9332	48	6	90	90	NUM
ct-9332	48	7	%	%	NOUN
ct-9332	48	8	,	,	PUNCT
ct-9332	48	9	but	but	CCONJ
ct-9332	48	10	in	in	ADP
ct-9332	48	11	some	some	DET
ct-9332	48	12	cases	case	NOUN
ct-9332	48	13	,	,	PUNCT
ct-9332	48	14	more	more	ADJ
ct-9332	48	15	than	than	ADP
ct-9332	48	16	5	5	NUM
ct-9332	48	17	injections	injection	NOUN
ct-9332	48	18	are	be	AUX
ct-9332	48	19	necessary	necessary	ADJ
ct-9332	48	20	to	to	PART
ct-9332	48	21	reach	reach	VERB
ct-9332	48	22	full	full	ADJ
ct-9332	48	23	recovery	recovery	NOUN
ct-9332	48	24	.	.	PUNCT
ct-9332	49	1	if	if	SCONJ
ct-9332	49	2	clinical	clinical	ADJ
ct-9332	49	3	signs	sign	NOUN
ct-9332	49	4	are	be	AUX
ct-9332	49	5	related	relate	VERB
ct-9332	49	6	to	to	ADP
ct-9332	49	7	exogenous	exogenous	ADJ
ct-9332	49	8	long	long	ADV
ct-9332	49	9	-	-	PUNCT
ct-9332	49	10	acting	act	VERB
ct-9332	49	11	progesterone	progesterone	NOUN
ct-9332	49	12	use	use	NOUN
ct-9332	49	13	,	,	PUNCT
ct-9332	49	14	treatment	treatment	NOUN
ct-9332	49	15	should	should	AUX
ct-9332	49	16	be	be	AUX
ct-9332	49	17	repeated	repeat	VERB
ct-9332	49	18	weekly	weekly	ADV
ct-9332	49	19	for	for	ADP
ct-9332	49	20	at	at	ADV
ct-9332	49	21	least	least	ADV
ct-9332	49	22	5	5	NUM
ct-9332	49	23	weeks	week	NOUN
ct-9332	49	24	,	,	PUNCT
ct-9332	49	25	even	even	ADV
ct-9332	49	26	if	if	SCONJ
ct-9332	49	27	regression	regression	NOUN
ct-9332	49	28	of	of	ADP
ct-9332	49	29	lesions	lesion	NOUN
ct-9332	49	30	occurred.9	occurred.9	VERB
ct-9332	49	31	final	final	ADJ
ct-9332	49	32	considerations	consideration	NOUN
ct-9332	49	33	since	since	SCONJ
ct-9332	49	34	the	the	DET
ct-9332	49	35	product	product	NOUN
ct-9332	49	36	is	be	AUX
ct-9332	49	37	oil	oil	NOUN
ct-9332	49	38	-	-	PUNCT
ct-9332	49	39	alcohol	alcohol	NOUN
ct-9332	49	40	based	base	VERB
ct-9332	49	41	,	,	PUNCT
ct-9332	49	42	the	the	DET
ct-9332	49	43	injection	injection	NOUN
ct-9332	49	44	needs	need	VERB
ct-9332	49	45	to	to	PART
ct-9332	49	46	be	be	AUX
ct-9332	49	47	subcutaneous	subcutaneous	ADJ
ct-9332	49	48	.	.	PUNCT
ct-9332	50	1	after	after	ADP
ct-9332	50	2	injection	injection	NOUN
ct-9332	50	3	,	,	PUNCT
ct-9332	50	4	a	a	DET
ct-9332	50	5	slight	slight	ADJ
ct-9332	50	6	massage	massage	NOUN
ct-9332	50	7	of	of	ADP
ct-9332	50	8	the	the	DET
ct-9332	50	9	injection	injection	NOUN
ct-9332	50	10	site	site	NOUN
ct-9332	50	11	is	be	AUX
ct-9332	50	12	necessary	necessary	ADJ
ct-9332	50	13	.	.	PUNCT
ct-9332	51	1	if	if	SCONJ
ct-9332	51	2	the	the	DET
ct-9332	51	3	volume	volume	NOUN
ct-9332	51	4	of	of	ADP
ct-9332	51	5	the	the	DET
ct-9332	51	6	injected	inject	VERB
ct-9332	51	7	solution	solution	NOUN
ct-9332	51	8	exceeds	exceed	VERB
ct-9332	51	9	5	5	NUM
ct-9332	51	10	ml	ml	NOUN
ct-9332	51	11	,	,	PUNCT
ct-9332	51	12	the	the	DET
ct-9332	51	13	drug	drug	NOUN
ct-9332	51	14	must	must	AUX
ct-9332	51	15	be	be	AUX
ct-9332	51	16	injected	inject	VERB
ct-9332	51	17	at	at	ADP
ct-9332	51	18	multiple	multiple	ADJ
ct-9332	51	19	sites	site	NOUN
ct-9332	51	20	.	.	PUNCT
ct-9332	52	1	local	local	ADJ
ct-9332	52	2	pain	pain	NOUN
ct-9332	52	3	at	at	ADP
ct-9332	52	4	the	the	DET
ct-9332	52	5	site	site	NOUN
ct-9332	52	6	of	of	ADP
ct-9332	52	7	injection	injection	NOUN
ct-9332	52	8	(	(	PUNCT
ct-9332	52	9	sometimes	sometimes	ADV
ct-9332	52	10	edema	edema	NOUN
ct-9332	52	11	,	,	PUNCT
ct-9332	52	12	skin	skin	NOUN
ct-9332	52	13	thickening	thickening	NOUN
ct-9332	52	14	,	,	PUNCT
ct-9332	52	15	ulceration	ulceration	NOUN
ct-9332	52	16	,	,	PUNCT
ct-9332	52	17	and	and	CCONJ
ct-9332	52	18	localized	localized	ADJ
ct-9332	52	19	lymph	lymph	NOUN
ct-9332	52	20	node	node	ADJ
ct-9332	52	21	enlargement	enlargement	NOUN
ct-9332	52	22	)	)	PUNCT
ct-9332	52	23	can	can	AUX
ct-9332	52	24	be	be	AUX
ct-9332	52	25	observed	observe	VERB
ct-9332	52	26	.	.	PUNCT
ct-9332	53	1	in	in	ADP
ct-9332	53	2	case	case	NOUN
ct-9332	53	3	of	of	ADP
ct-9332	53	4	show	show	NOUN
ct-9332	53	5	dogs	dog	NOUN
ct-9332	53	6	and	and	CCONJ
ct-9332	53	7	dark	dark	ADJ
ct-9332	53	8	color	color	NOUN
ct-9332	53	9	-	-	PUNCT
ct-9332	53	10	coated	coat	VERB
ct-9332	53	11	animals	animal	NOUN
ct-9332	53	12	,	,	PUNCT
ct-9332	53	13	we	we	PRON
ct-9332	53	14	prefer	prefer	VERB
ct-9332	53	15	less	less	ADV
ct-9332	53	16	exposed	expose	VERB
ct-9332	53	17	areas	area	NOUN
ct-9332	53	18	as	as	ADP
ct-9332	53	19	injection	injection	NOUN
ct-9332	53	20	sites	site	NOUN
ct-9332	53	21	.	.	PUNCT
ct-9332	54	1	in	in	ADP
ct-9332	54	2	our	our	PRON
ct-9332	54	3	experience	experience	NOUN
ct-9332	54	4	,	,	PUNCT
ct-9332	54	5	systemic	systemic	ADJ
ct-9332	54	6	adverse	adverse	ADJ
ct-9332	54	7	effects	effect	NOUN
ct-9332	54	8	as	as	ADP
ct-9332	54	9	anorexia	anorexia	NOUN
ct-9332	54	10	,	,	PUNCT
ct-9332	54	11	excitation	excitation	NOUN
ct-9332	54	12	,	,	PUNCT
ct-9332	54	13	depression	depression	NOUN
ct-9332	54	14	,	,	PUNCT
ct-9332	54	15	vomiting	vomiting	NOUN
ct-9332	54	16	and	and	CCONJ
ct-9332	54	17	diarrhea	diarrhea	NOUN
ct-9332	54	18	are	be	AUX
ct-9332	54	19	infrequently	infrequently	ADV
ct-9332	54	20	observed	observe	VERB
ct-9332	54	21	.	.	PUNCT
ct-9332	55	1	alizin	alizin	NOUN
ct-9332	55	2	®	®	PROPN
ct-9332	55	3	is	be	AUX
ct-9332	55	4	a	a	DET
ct-9332	55	5	welcome	welcome	ADJ
ct-9332	55	6	addition	addition	NOUN
ct-9332	55	7	in	in	ADP
ct-9332	55	8	the	the	DET
ct-9332	55	9	therapy	therapy	NOUN
ct-9332	55	10	and	and	CCONJ
ct-9332	55	11	management	management	NOUN
ct-9332	55	12	of	of	ADP
ct-9332	55	13	small	small	ADJ
ct-9332	55	14	animal	animal	NOUN
ct-9332	55	15	reproductive	reproductive	ADJ
ct-9332	55	16	problems	problem	NOUN
ct-9332	55	17	.	.	PUNCT
ct-9332	56	1	conflict	conflict	NOUN
ct-9332	56	2	of	of	ADP
ct-9332	56	3	interest	interest	NOUN
ct-9332	56	4	none	none	NOUN
ct-9332	56	5	to	to	PART
ct-9332	56	6	report	report	VERB
ct-9332	56	7	.	.	PUNCT
ct-9332	57	1	references	reference	NOUN
ct-9332	57	2	1	1	NUM
ct-9332	57	3	.	.	PUNCT
ct-9332	58	1	gogny	gogny	PROPN
ct-9332	58	2	a	a	PRON
ct-9332	58	3	,	,	PUNCT
ct-9332	58	4	fieni	fieni	ADJ
ct-9332	58	5	f	f	NOUN
ct-9332	58	6	:	:	PUNCT
ct-9332	59	1	aglepristone	aglepristone	ADJ
ct-9332	59	2	:	:	PUNCT
ct-9332	59	3	a	a	DET
ct-9332	59	4	review	review	NOUN
ct-9332	59	5	on	on	ADP
ct-9332	59	6	its	its	PRON
ct-9332	59	7	clinical	clinical	ADJ
ct-9332	59	8	use	use	NOUN
ct-9332	59	9	in	in	ADP
ct-9332	59	10	animals	animal	NOUN
ct-9332	59	11	.	.	PUNCT
ct-9332	60	1	theriogenology	theriogenology	NOUN
ct-9332	60	2	2016;85:555	2016;85:555	PROPN
ct-9332	60	3	-	-	SYM
ct-9332	60	4	566	566	NUM
ct-9332	60	5	.	.	NOUN
ct-9332	60	6	2	2	NUM
ct-9332	60	7	.	.	X
ct-9332	60	8	kowalewski	kowalewski	PROPN
ct-9332	60	9	m	m	PROPN
ct-9332	60	10	,	,	PUNCT
ct-9332	60	11	pereira	pereira	PROPN
ct-9332	60	12	mt	mt	PROPN
ct-9332	60	13	,	,	PUNCT
ct-9332	60	14	papa	papa	VERB
ct-9332	60	15	p	p	PROPN
ct-9332	60	16	et	et	PROPN
ct-9332	60	17	al	al	PROPN
ct-9332	60	18	:	:	PUNCT
ct-9332	60	19	progesterone	progesterone	NOUN
ct-9332	60	20	receptor	receptor	NOUN
ct-9332	60	21	blockers	blocker	NOUN
ct-9332	60	22	:	:	PUNCT
ct-9332	60	23	historical	historical	ADJ
ct-9332	60	24	perspective	perspective	NOUN
ct-9332	60	25	,	,	PUNCT
ct-9332	60	26	mode	mode	NOUN
ct-9332	60	27	of	of	ADP
ct-9332	60	28	function	function	NOUN
ct-9332	60	29	and	and	CCONJ
ct-9332	60	30	insights	insight	NOUN
ct-9332	60	31	into	into	ADP
ct-9332	60	32	clinical	clinical	ADJ
ct-9332	60	33	and	and	CCONJ
ct-9332	60	34	scientific	scientific	ADJ
ct-9332	60	35	applications	application	NOUN
ct-9332	60	36	.	.	PUNCT
ct-9332	61	1	tierarztliche	tierarztliche	PROPN
ct-9332	61	2	praxis	praxi	VERB
ct-9332	61	3	ausgabe	ausgabe	PROPN
ct-9332	61	4	k	k	PROPN
ct-9332	61	5	:	:	PUNCT
ct-9332	61	6	kleintiere	kleintiere	ADV
ct-9332	61	7	–	–	PUNCT
ct-9332	61	8	heimtiere	heimtiere	ADV
ct-9332	61	9	.	.	PUNCT
ct-9332	62	1	2020;48:433	2020;48:433	NUM
ct-9332	62	2	-	-	SYM
ct-9332	62	3	440	440	NUM
ct-9332	62	4	.	.	PUNCT
ct-9332	63	1	3	3	X
ct-9332	63	2	.	.	X
ct-9332	63	3	goericke	goericke	PROPN
ct-9332	63	4	-	-	PUNCT
ct-9332	63	5	pesch	pesch	PROPN
ct-9332	63	6	s	s	PROPN
ct-9332	63	7	,	,	PUNCT
ct-9332	63	8	georgiev	georgiev	NOUN
ct-9332	63	9	p	p	NOUN
ct-9332	63	10	,	,	PUNCT
ct-9332	63	11	wehrend	wehrend	ADJ
ct-9332	63	12	a	a	DET
ct-9332	63	13	:	:	PUNCT
ct-9332	63	14	prevention	prevention	NOUN
ct-9332	63	15	of	of	ADP
ct-9332	63	16	pregnancy	pregnancy	NOUN
ct-9332	63	17	in	in	ADP
ct-9332	63	18	cats	cat	NOUN
ct-9332	63	19	using	use	VERB
ct-9332	63	20	aglepristone	aglepristone	ADV
ct-9332	63	21	on	on	ADP
ct-9332	63	22	days	day	NOUN
ct-9332	63	23	5	5	NUM
ct-9332	63	24	and	and	CCONJ
ct-9332	63	25	6	6	NUM
ct-9332	63	26	after	after	ADP
ct-9332	63	27	mating	mating	NOUN
ct-9332	63	28	.	.	PUNCT
ct-9332	64	1	theriogenology	theriogenology	NOUN
ct-9332	64	2	2010;74:304	2010;74:304	NUM
ct-9332	64	3	-	-	SYM
ct-9332	64	4	310	310	NUM
ct-9332	64	5	.	.	NOUN
ct-9332	64	6	4	4	NUM
ct-9332	64	7	.	.	X
ct-9332	64	8	contri	contri	PROPN
ct-9332	64	9	a	a	PRON
ct-9332	64	10	,	,	PUNCT
ct-9332	64	11	gloria	gloria	PROPN
ct-9332	64	12	a	a	NOUN
ct-9332	64	13	,	,	PUNCT
ct-9332	64	14	carluccio	carluccio	PROPN
ct-9332	64	15	a	a	X
ct-9332	64	16	,	,	PUNCT
ct-9332	64	17	et	et	PROPN
ct-9332	64	18	al	al	PROPN
ct-9332	64	19	:	:	PUNCT
ct-9332	64	20	effectiveness	effectiveness	NOUN
ct-9332	64	21	of	of	ADP
ct-9332	64	22	a	a	DET
ct-9332	64	23	modified	modified	ADJ
ct-9332	64	24	administration	administration	NOUN
ct-9332	64	25	protocol	protocol	NOUN
ct-9332	64	26	for	for	ADP
ct-9332	64	27	the	the	DET
ct-9332	64	28	medical	medical	ADJ
ct-9332	64	29	treatment	treatment	NOUN
ct-9332	64	30	of	of	ADP
ct-9332	64	31	canine	canine	NOUN
ct-9332	64	32	pyometra	pyometra	NOUN
ct-9332	64	33	.	.	PUNCT
ct-9332	65	1	vet	vet	NOUN
ct-9332	65	2	res	re	NOUN
ct-9332	65	3	comm	comm	NOUN
ct-9332	65	4	2015;39:1	2015;39:1	NUM
ct-9332	65	5	-	-	PUNCT
ct-9332	65	6	5	5	NUM
ct-9332	65	7	.	.	NOUN
ct-9332	65	8	5	5	NUM
ct-9332	65	9	.	.	X
ct-9332	65	10	fieni	fieni	PROPN
ct-9332	65	11	f	f	PROPN
ct-9332	65	12	,	,	PUNCT
ct-9332	65	13	gogny	gogny	NOUN
ct-9332	65	14	a	a	PRON
ct-9332	65	15	:	:	PUNCT
ct-9332	65	16	clinical	clinical	ADJ
ct-9332	65	17	evaluation	evaluation	NOUN
ct-9332	65	18	of	of	ADP
ct-9332	65	19	the	the	DET
ct-9332	65	20	use	use	NOUN
ct-9332	65	21	of	of	ADP
ct-9332	65	22	aglepristone	aglepristone	NOUN
ct-9332	65	23	associated	associate	VERB
ct-9332	65	24	with	with	ADP
ct-9332	65	25	oxytocin	oxytocin	NOUN
ct-9332	65	26	to	to	PART
ct-9332	65	27	induce	induce	VERB
ct-9332	65	28	parturition	parturition	NOUN
ct-9332	65	29	in	in	ADP
ct-9332	65	30	bitch	bitch	NOUN
ct-9332	65	31	.	.	PUNCT
ct-9332	66	1	reprod	reprod	PROPN
ct-9332	66	2	domest	domest	PROPN
ct-9332	66	3	anim	anim	PROPN
ct-9332	66	4	2009;44:167	2009;44:167	PROPN
ct-9332	66	5	-	-	SYM
ct-9332	66	6	169	169	NUM
ct-9332	66	7	.	.	PUNCT
ct-9332	67	1	6	6	NUM
ct-9332	67	2	.	.	X
ct-9332	67	3	fontbonne	fontbonne	PROPN
ct-9332	67	4	a	a	PRON
ct-9332	67	5	,	,	PUNCT
ct-9332	67	6	fontaine	fontaine	PROPN
ct-9332	67	7	e	e	PROPN
ct-9332	67	8	,	,	PUNCT
ct-9332	67	9	lévy	lévy	ADJ
ct-9332	67	10	x	x	NOUN
ct-9332	67	11	,	,	PUNCT
ct-9332	67	12	et	et	PROPN
ct-9332	67	13	al	al	PROPN
ct-9332	67	14	:	:	PUNCT
ct-9332	67	15	induction	induction	NOUN
ct-9332	67	16	of	of	ADP
ct-9332	67	17	parturition	parturition	NOUN
ct-9332	67	18	with	with	ADP
ct-9332	67	19	aglepristone	aglepristone	NOUN
ct-9332	67	20	in	in	ADP
ct-9332	67	21	various	various	ADJ
ct-9332	67	22	sized	sized	ADJ
ct-9332	67	23	bitches	bitch	NOUN
ct-9332	67	24	of	of	ADP
ct-9332	67	25	different	different	ADJ
ct-9332	67	26	breeds	breed	NOUN
ct-9332	67	27	.	.	PUNCT
ct-9332	68	1	reprod	reprod	PROPN
ct-9332	68	2	domest	domest	PROPN
ct-9332	68	3	anim	anim	PROPN
ct-9332	68	4	2009;44:170	2009;44:170	PROPN
ct-9332	68	5	-	-	PUNCT
ct-9332	68	6	173	173	NUM
ct-9332	68	7	.	.	PUNCT
ct-9332	68	8	7	7	X
ct-9332	68	9	.	.	X
ct-9332	69	1	lopate	lopate	PROPN
ct-9332	69	2	c	c	NOUN
ct-9332	69	3	:	:	PUNCT
ct-9332	69	4	gestational	gestational	ADJ
ct-9332	69	5	aging	aging	NOUN
ct-9332	69	6	and	and	CCONJ
ct-9332	69	7	determination	determination	NOUN
ct-9332	69	8	of	of	ADP
ct-9332	69	9	parturition	parturition	NOUN
ct-9332	69	10	date	date	NOUN
ct-9332	69	11	in	in	ADP
ct-9332	69	12	the	the	DET
ct-9332	69	13	bitch	bitch	NOUN
ct-9332	69	14	and	and	CCONJ
ct-9332	69	15	queen	queen	NOUN
ct-9332	69	16	using	use	VERB
ct-9332	69	17	ultrasonography	ultrasonography	NOUN
ct-9332	69	18	and	and	CCONJ
ct-9332	69	19	radiography	radiography	NOUN
ct-9332	69	20	.	.	PUNCT
ct-9332	70	1	vet	vet	NOUN
ct-9332	70	2	clin	clin	PROPN
ct-9332	70	3	north	north	PROPN
ct-9332	70	4	am	be	AUX
ct-9332	70	5	small	small	ADJ
ct-9332	70	6	anim	anim	NOUN
ct-9332	70	7	pract	pract	NOUN
ct-9332	70	8	2018;48:617	2018;48:617	PROPN
ct-9332	70	9	-	-	NOUN
ct-9332	70	10	638	638	NUM
ct-9332	70	11	.	.	PUNCT
ct-9332	71	1	8	8	NUM
ct-9332	71	2	.	.	PUNCT
ct-9332	72	1	roos	roos	PROPN
ct-9332	72	2	j	j	PROPN
ct-9332	72	3	,	,	PUNCT
ct-9332	72	4	maenhoudt	maenhoudt	ADJ
ct-9332	72	5	c	c	NOUN
ct-9332	72	6	,	,	PUNCT
ct-9332	72	7	zilberstein	zilberstein	PROPN
ct-9332	72	8	l	l	NOUN
ct-9332	72	9	,	,	PUNCT
ct-9332	72	10	et	et	PROPN
ct-9332	72	11	al	al	PROPN
ct-9332	72	12	:	:	PUNCT
ct-9332	72	13	neonatal	neonatal	ADJ
ct-9332	72	14	puppy	puppy	NOUN
ct-9332	72	15	survival	survival	NOUN
ct-9332	72	16	after	after	ADP
ct-9332	72	17	planned	plan	VERB
ct-9332	72	18	caesarean	caesarean	ADJ
ct-9332	72	19	section	section	NOUN
ct-9332	72	20	in	in	ADP
ct-9332	72	21	the	the	DET
ct-9332	72	22	bitch	bitch	NOUN
ct-9332	72	23	using	use	VERB
ct-9332	72	24	aglepristone	aglepristone	ADV
ct-9332	72	25	as	as	ADP
ct-9332	72	26	a	a	DET
ct-9332	72	27	primer	primer	NOUN
ct-9332	72	28	:	:	PUNCT
ct-9332	72	29	a	a	DET
ct-9332	72	30	retrospective	retrospective	ADJ
ct-9332	72	31	study	study	NOUN
ct-9332	72	32	on	on	ADP
ct-9332	72	33	74	74	NUM
ct-9332	72	34	cases	case	NOUN
ct-9332	72	35	.	.	PUNCT
ct-9332	73	1	reprod	reprod	PROPN
ct-9332	73	2	dom	dom	PROPN
ct-9332	73	3	anim	anim	PROPN
ct-9332	73	4	2018;53	2018;53	PROPN
ct-9332	73	5	(	(	PUNCT
ct-9332	73	6	suppl	suppl	NOUN
ct-9332	73	7	3):85	3):85	NUM
ct-9332	73	8	-	-	SYM
ct-9332	73	9	95	95	NUM
ct-9332	73	10	.	.	PUNCT
ct-9332	74	1	9	9	NUM
ct-9332	74	2	.	.	X
ct-9332	75	1	jurka	jurka	PROPN
ct-9332	75	2	p	p	X
ct-9332	75	3	,	,	PUNCT
ct-9332	75	4	max	max	PROPN
ct-9332	75	5	a	a	DET
ct-9332	75	6	:	:	PUNCT
ct-9332	75	7	treatment	treatment	NOUN
ct-9332	75	8	of	of	ADP
ct-9332	75	9	fibroadenomatosis	fibroadenomatosis	NOUN
ct-9332	75	10	in	in	ADP
ct-9332	75	11	14	14	NUM
ct-9332	75	12	cats	cat	NOUN
ct-9332	75	13	with	with	ADP
ct-9332	75	14	aglepristone	aglepristone	ADJ
ct-9332	75	15	–	–	PUNCT
ct-9332	75	16	changes	change	NOUN
ct-9332	75	17	in	in	ADP
ct-9332	75	18	blood	blood	NOUN
ct-9332	75	19	parameters	parameter	NOUN
ct-9332	75	20	and	and	CCONJ
ct-9332	75	21	follow‐up	follow‐up	NOUN
ct-9332	75	22	.	.	PUNCT
ct-9332	76	1	vet	vet	NOUN
ct-9332	76	2	record	record	NOUN
ct-9332	76	3	case	case	NOUN
ct-9332	76	4	reports	report	VERB
ct-9332	76	5	2013;1(1	2013;1(1	NUM
ct-9332	76	6	)	)	PUNCT
ct-9332	76	7	e657rep	e657rep	ADJ
ct-9332	76	8	https://doi.org/10.1136/vetreccr.165.22.657rep	https://doi.org/10.1136/vetreccr.165.22.657rep	NOUN
ct-9332	76	9	clinical	clinical	ADJ
ct-9332	76	10	theriogenology	theriogenology	NOUN
ct-9332	76	11	2021	2021	NUM
ct-9332	76	12	;	;	PUNCT
ct-9332	76	13	13	13	NUM
ct-9332	76	14	:	:	SYM
ct-9332	76	15	160	160	NUM
ct-9332	76	16	antiprogestin	antiprogestin	NOUN
ct-9332	76	17	use	use	NOUN
ct-9332	76	18	in	in	ADP
ct-9332	76	19	europe	europe	PROPN